Surrey researchers Sign in
IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype: Walter O, Prasad M, Lu S, et al (UMass Memorial Med Ctr, Worcester, MA) Hum Pathol 40:1528-1533, 2009
Journal article   Peer reviewed

IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype: Walter O, Prasad M, Lu S, et al (UMass Memorial Med Ctr, Worcester, MA) Hum Pathol 40:1528-1533, 2009

Breast diseases, Vol.21(2), pp.145-146
2010

Abstract

1 B

Metrics

3 Record Views

Details

Usage Policy